Skip to main content
Advantage of Abemaciclib Plus Endocrine Therapy for Early Breast Cancer Endures at 5 Years
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Advantage of Abemaciclib Plus Endocrine Therapy for Early Breast Cancer Endures at 5 Years
User login
Username
Password
Reset your password
Concept
Lead
score
Breast Cancer
1
1
Breast
0
0.58
Cancer
0
0.58
Endocrine Therapy
0
0.99
Breast Surgery
0
0.44
Cancer Risk
0
0.44
Genomic Medicine
0
0.4
Thromboembolism
0
0.18
Biomarker
0
0.13
Surgery
0
0.13
Adjuvant Setting
0
0.09
Epidermal Growth Factor Receptor
0
0.09
Receptors
0
0.09
Specialty
Lead
score
Hematology-Oncology
1
1
Ob/Gyn & Women's Health
0
0.9
Pharmacist
0
0.8
Edit Tags